FDA scientists remain unconvinced In recent years, the FDA has warned Americans about the risks of injecting peptides like BPC-157 and TB-500, another compound set for review
Trials of unpatentable molecules typically depend on philanthropic, academic, or government funding, and that pipeline has not yet materialised for BPC-157
While BPC-157 is renowned for its relative stability in gastric juice, why create a more hostile environment than necessary
After eliminating duplicates, 51 targets with standardized names were acquired
What stands out most is not simply cartilage regrowth, but the mechanism: targeting an age-associated enzyme (15-PGDH) to reprogram existing chondrocytes toward a younger, regenerative statewithout stem cells